Nationwide Implementation of Neoadjuvant Nivolumab-Based Chemo-Immunotherapy for Resectable NSCLC: Surgical Outcomes from a Prospective Multicenter Study

Jiri Vachtenheim Jr, Fernando Casas-Mendez, Rene Novysedlak, Janis Tavandzis, Linda Capkova, Jaromir Vajter, Marek Szkorupa, Juraj Kultan, Alice Taskova, Martina Koziar Vasakova, Martin Skala, Martin Svaton, Vilem Maly, David Sulc, Ivo Hanke, Michal Hrnciarik, Ladislav Mitas, Monika Bratova, Lubomir Tulinsky, Radoslava Cernekova, Zuzana Ozaniak Strizova, Matyas Kuhn, Boris Sepesi, Jitka Palich Fucikova, Robert Lischke

Open source

DOI: 10.1245/s10434-026-20310-2
Published: 2026-07-30
Container: Annals of Surgical Oncology
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1245/s10434-026-20310-2,
  title = {Nationwide Implementation of Neoadjuvant Nivolumab-Based Chemo-Immunotherapy for Resectable NSCLC: Surgical Outcomes from a Prospective Multicenter Study},
  author = {Jiri Vachtenheim Jr and Fernando Casas-Mendez and Rene Novysedlak and Janis Tavandzis and Linda Capkova and Jaromir Vajter and Marek Szkorupa and Juraj Kultan and Alice Taskova and Martina Koziar Vasakova and Martin Skala and Martin Svaton and Vilem Maly and David Sulc and Ivo Hanke and Michal Hrnciarik and Ladislav Mitas and Monika Bratova and Lubomir Tulinsky and Radoslava Cernekova and Zuzana Ozaniak Strizova and Matyas Kuhn and Boris Sepesi and Jitka Palich Fucikova and Robert Lischke},
  year = {2026},
  journal = {Annals of Surgical Oncology},
  doi = {10.1245/s10434-026-20310-2},
  url = {https://doi.org/10.1245/s10434-026-20310-2}
}

RIS

TY  - JOUR
TI  - Nationwide Implementation of Neoadjuvant Nivolumab-Based Chemo-Immunotherapy for Resectable NSCLC: Surgical Outcomes from a Prospective Multicenter Study
AU  - Jiri Vachtenheim Jr
AU  - Fernando Casas-Mendez
AU  - Rene Novysedlak
AU  - Janis Tavandzis
AU  - Linda Capkova
AU  - Jaromir Vajter
AU  - Marek Szkorupa
AU  - Juraj Kultan
AU  - Alice Taskova
AU  - Martina Koziar Vasakova
AU  - Martin Skala
AU  - Martin Svaton
AU  - Vilem Maly
AU  - David Sulc
AU  - Ivo Hanke
AU  - Michal Hrnciarik
AU  - Ladislav Mitas
AU  - Monika Bratova
AU  - Lubomir Tulinsky
AU  - Radoslava Cernekova
AU  - Zuzana Ozaniak Strizova
AU  - Matyas Kuhn
AU  - Boris Sepesi
AU  - Jitka Palich Fucikova
AU  - Robert Lischke
PY  - 2026
JO  - Annals of Surgical Oncology
DO  - 10.1245/s10434-026-20310-2
UR  - https://doi.org/10.1245/s10434-026-20310-2
ER  -

APA

Jr, J. V., Casas-Mendez, F., Novysedlak, R., Tavandzis, J., Capkova, L., Vajter, J., Szkorupa, M., Kultan, J., Taskova, A., Vasakova, M. K., Skala, M., Svaton, M., Maly, V., Sulc, D., Hanke, I., Hrnciarik, M., Mitas, L., Bratova, M., Tulinsky, L., Cernekova, R., Strizova, Z. O., Kuhn, M., Sepesi, B., Fucikova, J. P., & Lischke, R. (2026). Nationwide Implementation of Neoadjuvant Nivolumab-Based Chemo-Immunotherapy for Resectable NSCLC: Surgical Outcomes from a Prospective Multicenter Study. Annals of Surgical Oncology. https://doi.org/10.1245/s10434-026-20310-2

Source records

crossref · retrieved 2026-09-25T23:07:59.120Z